Los Angeles Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $123K | Buy |
+34,075
| New | +$123K | ﹤0.01% | 1240 |
|
|
2023
Q1 | – | Sell |
-175,048
| Closed | -$842K | – | 1169 |
|
|
2022
Q4 | $842K | Sell |
175,048
-2,100
| -1% | -$10.1K | ﹤0.01% | 748 |
|
|
2022
Q3 | $1.01M | Sell |
177,148
-24,326
| -12% | -$138K | 0.01% | 694 |
|
|
2022
Q2 | $1.43M | Sell |
201,474
-30,451
| -13% | -$216K | 0.01% | 615 |
|
|
2022
Q1 | $1.67M | Buy |
+231,925
| New | +$1.67M | 0.01% | 587 |
|